Enzyme augmentation therapy enhances the therapeutic efficacy of bone marrow transplantation in mucopolysaccharidosis type II mice
Kazumasa Akiyama(Jikei University School of Medicine), Toya Ohashi(Jikei University School of Medicine), Brett E. Crawford(BioMarin (United States)), Jillian R. Brown(APC Microbiome Institute), Hiromitsu Nakauchi(University of Tsukuba), Takashi Higuchi(Kyoto University), Yohta Shimada(Jikei University School of Medicine), Yoshikatsu Eto(Advanced Medical Research Institute), Makoto Ohtsu(Tokyo University of Science), Hiroshi Kobayashi(Jikei University School of Medicine), Takahiro Fukuda(Takarazuka City Hospital), Hiroyuki Ida(Fujieda Municipal General Hospital)
Cited by 16
Related Papers
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2016|538
Generation of Rejuvenated Antigen-Specific T Cells by Reprogramming to Pluripotency and Redifferentiation
|Cell stem cell|2013|412
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)
|Bone Marrow Transplantation|2015|387
Development of Defective and Persistent Sendai Virus Vector
|Journal of Biological Chemistry|2010|373
Transient activation of <i>c-MYC</i> expression is critical for efficient platelet generation from human induced pluripotent stem cells
|The Journal of Experimental Medicine|2010|347